AFT Pharmaceuticals Limited (AFP) Q2 2026 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Aft Pharmaceuticals Ltd..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.200 -- 00:00:04.124 I would now like to hand the conference over to Hartley Atkinson, CEO. 00:00:04.124 -- 00:00:05.845 Please go ahead. 00:00:05.845 -- 00:00:10.570 Hartley Atkinson Thank you very much and thank you everyone for joining our call today. 00:00:10.570 -- 00:00:13.973 What we'll do is we'll go through the presentation 00:00:13.973 -- 00:00:17.597 and then as has been mentioned have time for questions afterwards. 00:00:17.597 -- 00:00:22.842 I'll just read out the page numbers as well so that everyone knows where we're at 00:00:22.842 -- 00:00:28.228 in terms of the presentation pages. So look, first page obviously 00:00:28.228 -- 00:00:32.873 and then the second page is the disclaimer which I assume everyone is well aware of and 00:00:32.873 -- 00:00:38.540 has read. Moving now to page three which is just look a brief summary 00:00:38.540 -- 00:00:44.047 of kind of where we're at. We have our established Australia 00:00:44.047 -- 00:00:49.263 New Zealand business, pleased to have good sales growth of 23% 00:00:49.263 -- 00:00:54.472 across both Australia and New Zealand. Certainly Australia 00:00:54.472 -- 00:00:59.821 was very solid with 31% growth. New Zealand as well 00:00:59.821 -- 00:01:04.869 though grew at 8% and the OTC business which is the front end 00:01:04.869 -- 00:01:11.100 higher margin consumer business still grew at 12% so we're still getting good 00:01:11.100 -- 00:01:16.487 performance in the New Zealand market. And then looking across 00:01:16.487 -- 00:01:21.571 to the box on the right at the top, what we are putting a lot 00:01:21.571 -- 00:01:26.996 of work in at the moment is continuing to expand our global 00:01:26.996 -- 00:01:28.638 footprint, 00:01:28.638 -- 00:01:33.722 so Europe, the UK and the EU, North Ame...